symposium

Second International Symposium on Yeast Protein Science and Technology Concludes in Yichang

SHANGHAI, April 14, 2026 /PRNewswire/ -- The 2nd International Symposium on Yeast Protein Science and Technology, co-hosted by Angel Yeast (SH600298),…

6 days ago

HR Symposium 2026: Inspiring the Next Generation of Industry-Ready Professionals

"The future belongs to those who continuously learn, adapt, and evolve." — a thought that resonated strongly throughout the HR Symposium…

7 days ago

Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium

April 02, 2026 08:00 ET  | Source: Tvardi Therapeutics HOUSTON, April 02, 2026 (GLOBE NEWSWIRE) -- Tvardi Therapeutics, Inc. (“Tvardi”)…

3 weeks ago

Milken Institute Kicks Off Third Global Investors’ Symposium in Hong Kong

This year's event accentuates the megatrends shaping capital in an evolving world.HONG KONG, March 23, 2026 /PRNewswire/ -- Milken Institute's Global…

4 weeks ago

IFQM’S FIRST MSME SYMPOSIUM CALLS FOR A ‘NATIONAL QUALITY SPRINT’ TO INTEGRATE WITH GLOBAL VALUE CHAINS

250+ MSME CEOs, industry captains, and academia convene in Chennai Leaders from TVS, Boeing, Motherson, Maruti Suzuki, Cummins, L&T, Bosch, ZF, and…

1 month ago

Indian Foundation for Quality Management announces MSME Symposium 2026

Theme of the symposium  is India Needs a Resurgent MSME SectorCaptains of the industry, quality experts, academia, delegates to deliberate…

1 month ago

Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies

January 25, 2026 17:30 ET  | Source: AVITA Medical First surgeon-reported case using RECELL®, PermeaDerm®, and Cohealyx™ together in a…

3 months ago

NANOscientific Symposium Series 2025 Concludes Successfully, Marked by a Landmark Celebration of 40 Years of AFM at Stanford

STANFORD, Calif., Dec. 24, 2025 /PRNewswire/ -- The NANOscientific Symposium Series (NSS) 2025 has successfully concluded its global program, bringing together…

4 months ago

Menarini Group Presents Elacestrant (ORSERDU) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium

In addition, the expansive elacestrant clinical development program updates reinforce its potential as a backbone endocrine therapy in combination settings, as…

4 months ago

Wuxi Xishan Golden Autumn Investment and Cooperation Symposium Reports Strong Outcomes

WUXI, China, Nov. 9, 2025 /PRNewswire/ -- The 2025 Wuxi Xishan Golden Autumn Investment and Cooperation Symposium was held on…

5 months ago